Signal from the log
Revier Therapeutics
6 M€ · Seed · Germany · Biotech
Revier Therapeutics sort de l'ombre à Heidelberg avec des molécules orales qui inhibent sélectivement les histone désacétylases de classe IIa, contre l'insuffisance cardiaque à fraction d'éjection préservée et l'athérosclérose.
Verified
Announced on , logged by the watch of 28 August 2026.
- Operation
- Funding round
- Announced amount
- 6 M€
- Stage
- Seed
- Country
- Germany
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by KHAN Technology Transfer Fund II , with High-Tech Gründerfonds , VORNvc , Revier Invest Heidelberg
Provenance
Source eu-startups
Logged on 28 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.